Amylyx Pharmaceuticals (AMLX) Asset Utilization Ratio (2022 - 2025)
Historic Asset Utilization Ratio for Amylyx Pharmaceuticals (AMLX) over the last 4 years, with Q3 2025 value amounting to 0.09.
- Amylyx Pharmaceuticals' Asset Utilization Ratio fell 8734.12% to 0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09, marking a year-over-year decrease of 8734.12%. This contributed to the annual value of 0.32 for FY2024, which is 6614.71% down from last year.
- Amylyx Pharmaceuticals' Asset Utilization Ratio amounted to 0.09 in Q3 2025, which was down 8734.12% from 0.13 recorded in Q2 2025.
- Amylyx Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.93 for Q1 2024, and its period low was 0.0 during Q2 2022.
- In the last 4 years, Amylyx Pharmaceuticals' Asset Utilization Ratio had a median value of 0.28 in 2023 and averaged 0.39.
- Per our database at Business Quant, Amylyx Pharmaceuticals' Asset Utilization Ratio soared by 4468287.32% in 2023 and then tumbled by 8734.12% in 2025.
- Quarter analysis of 4 years shows Amylyx Pharmaceuticals' Asset Utilization Ratio stood at 0.09 in 2022, then soared by 826.71% to 0.88 in 2023, then plummeted by 40.3% to 0.52 in 2024, then plummeted by 82.02% to 0.09 in 2025.
- Its Asset Utilization Ratio was 0.09 in Q3 2025, compared to 0.13 in Q2 2025 and 0.13 in Q1 2025.